Drawing based on the label description. No photo yet.
“Capsules: 50 mg hard gelatin capsule with yellow opaque body and light orange opaque cap imprinted "APO N50" in black ink”
APO N50 pill
Pill with imprint APO N50 is orange & yellow, capsule, 14 mm and has been identified as Nilotinib 50 mg. It is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors. It is supplied by Apotex Corp.
Nilotinib 50 mg
- Imprint
- APO N50
- Strength
- 50 mg
- Used for
- Accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors
- Color
- Orange, Yellow
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Apotex Corp
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 60505-3803, 60505-3803-7
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Nilotinib used for?
Nilotinib is used for accelerated phase myeloid leukemia, chronic-phase myeloid leukemia and gastrointestinal stromal tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Adult Patients With Newly Diagnosed Ph+ CML-CP
Nilotinib Capsules is indicated for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Adult Patients With Resistant or Intolerant Ph+ CML-CP and CML-AP
Nilotinib Capsules is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.
Additional pediatric use information is approved for Novartis Pharmaceuticals Corporation’s Tasigna ® (nilotinib) capsules. However, due to Novartis Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
From the FDA-approved label on DailyMed (published Sep 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows APO N50. The parts can be split between the two sides, so turn the pill over and check both.
- It is orange & yellow, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Nilotinib
Inactive: Silicon Dioxide, Crospovidone (120 .mu.m), Gelatin, Unspecified, Lactose Monohydrate, Magnesium Stearate, Ferric Oxide Red, Titanium Dioxide, Ferric Oxide Yellow, Poloxamer 188, Ammonia, Ferrosoferric Oxide, Propylene Glycol, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
SD TC 1 mg
Tacrolimus 1 mg
Orange & yellow, capsule, 14 mm
Used for eczema
-
423
Telmisartan and Hydrochlorothiazide 40 mg / 12.5 mg
Orange & white, capsule, 15 mm
Used for high blood pressure
-
B15
Cyclobenzaprine Hydrochloride 15 mg
Orange, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
B15
Cyclobenzaprine HCl ER 15 mg
Orange, capsule, 14 mm
Used for pain
-
B15
Cyclobenzaprine HCl 15 mg
Orange, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
R 30
Captopril and Hydrochlorothiazide 50 mg / 25 mg
Orange, capsule, 15 mm
Used for high blood pressure
Other Nilotinib pills
- RDY 150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- MN4 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- H 23 Nilotinib 150 mg Pink, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- NVR BCR Nilotinib 150 mg Red, capsule, 22 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- APO N150 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- N12 Nilotinib 150 mg Red, capsule, 19 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- Cipla 031150mg Nilotinib 150 mg Red, capsule, 20 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia
- RDY Nilotinib Hydrochloride Monohydrate 150 mg Red, capsule Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia